Mountain Pacific Investment Advisers’s Eli Lilly LLY Stock Holding History

Mountain Pacific Investment Advisers’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$378K	Hold	315	–	–	0.06%	119
2026 Q1	$290K	Hold	315	–	–	0.05%	125
2025 Q4	$339K	Sell	315 -529	-63%	-$506K	0.05%	124
2025 Q3	$644K	Hold	844	–	–	0.1%	97
2025 Q2	$658K	Buy	844 +489	+138%	+$380K	0.05%	97
2025 Q1	$293K	Hold	355	–	–	0.02%	131
2024 Q4	$274K	Sell	355 -30	-8%	-$24.8K	0.02%	125
2024 Q3	$341K	Hold	385	–	–	0.02%	125
2024 Q2	$349K	Hold	385	–	–	0.03%	122
2024 Q1	$300K	Hold	385	–	–	0.02%	126
2023 Q4	$224K	Sell	385 -25	-6%	-$14.6K	0.01%	129
2023 Q3	$220K	Buy	+410	New	+$211K	0.02%	126

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mountain Pacific Investment Advisers's LLY Position: Q2 2026 in Review

Mountain Pacific Investment Advisers held its Eli Lilly (LLY) position steady in Q2 2026 at 315 shares worth $378K. The position accounts for 0.06% of the portfolio, ranked #119.

Mountain Pacific Investment Advisers first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $658K in Q2 2025. 4,643 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Mountain Pacific Investment Advisers held 315 shares of Eli Lilly worth $378K as of Q2 2026.
Mountain Pacific Investment Advisers left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.06% of Mountain Pacific Investment Advisers's portfolio in Q2 2026, its #119 holding.
Mountain Pacific Investment Advisers first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
Mountain Pacific Investment Advisers's Eli Lilly position peaked at $658K in Q2 2025.
4,643 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mountain Pacific Investment Advisers's 13F filing for Q2 2026, filed 30 Jul 2026.